Journal of Computer-Aided Molecular Design

, Volume 21, Issue 10–11, pp 575–590 | Cite as

Pharmacophore modeling and parallel screening for PPAR ligands

  • Patrick Markt
  • Daniela Schuster
  • Johannes Kirchmair
  • Christian Laggner
  • Thierry Langer
Article

Abstract

We describe the generation and validation of pharmacophore models for PPARs, as well as a large scale validation of the parallel screening approach by screening PPAR ligands against a large database of structure-based models. A large test set of 357 PPAR ligands was screened against 48 PPAR models to determine the best models for agonists of PPAR-α, PPAR-δ, and PPAR-γ. Afterwards, a parallel screen was performed using the 357 PPAR ligands and 47 structure-based models for PPARs, which were integrated into a 1537 models comprising in-house pharmacophore database, to assess the enrichment of PPAR ligands within the PPAR hypotheses. For these purposes, we categorized the 1537 database models into 181 protein targets and developed a score that ranks the retrieved targets for each ligand. Thus, we tried to find out if the concept of parallel screening is able to predict the correct pharmacological target for a set of compounds. The PPAR target was ranked first more often than any other target. This confirms the ability of parallel screening to forecast the pharmacological active target for a set of compounds.

Keywords

PPAR LigandScout ilib:diverse Virtual screening Parallel screening Pharmacophore modelling Activity profiling Target fishing 

Supplementary material

10822_2007_9140_MOESM1_ESM.doc (1.1 mb)
(DOC 1111 kb)

References

  1. 1.
    Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV (1999) Mol Cell 3:397CrossRefGoogle Scholar
  2. 2.
    Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA (2006) Arterioscler Thromb Vasc Biol 26:28CrossRefGoogle Scholar
  3. 3.
    Cabrero A, Llaverias G, Roglans N, Alegret M, Sanchez R, Adzet T, Laguna JC, Vazquez M (1999) Biochem Biophys Res Commun 260:547CrossRefGoogle Scholar
  4. 4.
    Burgermeister E, Schnoebelen A, Flament A, Benz J, Stihle M, Gsell B, Rufer A, Ruf A, Kuhn B, Marki HP, Mizrahi J, Sebokova E, Niesor E, Meyer M (2006) Mol Endocrinol 20:809CrossRefGoogle Scholar
  5. 5.
    Willson TM, Brown PJ, Sternbach DD, Henke BR (2000) J Med Chem 43:527CrossRefGoogle Scholar
  6. 6.
    Tenenbaum A, Motro M, Fisman EZ (2005) Cardiovasc Diabetol 4:14CrossRefGoogle Scholar
  7. 7.
    Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RTJ, Mckee DD, Moore JT, Willson TM (2001) Proc Natl Acad Sci USA 98:13919CrossRefGoogle Scholar
  8. 8.
    Ebdrup S, Pettersson I, Rasmussen HB, Deussen HJ, Frost JA, Mortensen SB, Fleckner J, Pridal L, Nygaard L, Sauerberg P (2003) J Med Chem 46:1306CrossRefGoogle Scholar
  9. 9.
    Mahindroo N, Wang CC, Liao CC, Huang CF, Lu IL, Lien TW, Peng YH, Huang WJ, Lin YT, Hsu MC, Lin CH, Tsai CH, Hsu JT, Chen X, Lyu PC, Chao YS, Wu SY, Hsieh HP (2006) J Med Chem 49:1212CrossRefGoogle Scholar
  10. 10.
    Wolber G, Langer T (2005) J Chem Inf Model 45:160CrossRefGoogle Scholar
  11. 11.
    Oberfield JL, Collins JL, Holmes CP, Goreham DM, Cooper JP, Cobb JE, Lenhard JM, Hull-Ryde EA, Mohr CP, Blanchard SG, Parks DJ, Moore LB, Lehmann JM, Plunket K, Miller AB, Milburn MV, Kliewer SA, Willson TM (1999) Proc Natl Acad Sci USA 96:6102CrossRefGoogle Scholar
  12. 12.
    Kapoor A, Kashaw SK, Saxena AK (2004) Med Chem Res 13:770CrossRefGoogle Scholar
  13. 13.
    Rathi L, Kashaw SK, Dixit A, Pandey G, Saxena AK (2004) Bioorg Med Chem 12:63CrossRefGoogle Scholar
  14. 14.
    Xu XY, Cheng F, Shen JH, Luo XM, Chen LL, Yue LD, Du Y, Ye F, Jiang SH, Zhu DY, Jiang HL, Chen KX (2003) Int J Quantum Chem 93:405CrossRefGoogle Scholar
  15. 15.
    Iwata Y, Miyamoto S, Takamura M, Yanagisawa H, Kasuya A (2001) J Mol Graph Model 19:536–542CrossRefGoogle Scholar
  16. 16.
    Steindl TM, Schuster D, Laggner C, Langer T (2006) J Chem Inf Model 46:2146CrossRefGoogle Scholar
  17. 17.
    Pipeline Pilot, 5.0.1.100. Scitegic, 10188 Telesis Court., Suite 100, San Diego, CA 92121, USAGoogle Scholar
  18. 18.
    Catalyst, Version 4.11. Accelrys, 9685 Scranton Road, San Diego, CA 92121, USAGoogle Scholar
  19. 19.
    Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) Nucleic Acids Res 28:235CrossRefGoogle Scholar
  20. 20.
    Derwent World Drug Index 2003. Scientific, T., 3501 Market Street, Philadelphia, PA 19104, USAGoogle Scholar
  21. 21.
    ilib:diverse, 1.0.2. Inte:Ligand, Clemens Maria Hofbauer-G. 6, A-2344 Maria Enzersdorf, AustriaGoogle Scholar
  22. 22.
    Schuster D, Laggner C, Steindl TM, Palusczak A, Hartmann RW, Langer T (2006) J Chem Inf Model 46:1301CrossRefGoogle Scholar
  23. 23.
    Jacobsson M, Lidén P, Stjernschantz E, Boström H, Norinder U (2003) J Med Chem 46:5781CrossRefGoogle Scholar
  24. 24.
    Hecker EA, Duraiswami C, Andrea TA, Diller DJ (2002) J Chem Inf Comput Sci 42:1204CrossRefGoogle Scholar
  25. 25.
    Diller DJ, Li R (2003) J Med Chem 46:4638CrossRefGoogle Scholar
  26. 26.
    Clement OO, Mehl AT (2000) International University Line: La Jolla 71Google Scholar
  27. 27.
    Steindl T, Langer T (2004) J Chem Inf Comput Sci 44:1849CrossRefGoogle Scholar
  28. 28.
    Karanam BV, Hop CE, Liu DQ, Wallace M, Dean D, Satoh H, Komuro M, Awano K, Vincent SH (2004) Drug Metab Dispos 32:1015CrossRefGoogle Scholar
  29. 29.
    Schuster D, Laggner C, Steindl TM, Langer T (2006) Curr Drug Discov Technol 3:1CrossRefGoogle Scholar
  30. 30.
    Steindl TM, Crump CE, Hayden FG, Langer T (2005) J Med Chem 48:6250CrossRefGoogle Scholar
  31. 31.
    Koyama H, Boueres JK, Miller DJ, Berger JP, Macnaul KL, Wang PR, Ippolito MC, Wright SD, Agrawal AK, Moller DE, Sahoo SP (2005) Bioorg Med Chem Lett 15:3347CrossRefGoogle Scholar
  32. 32.
    Shi GQ, Dropinski JF, Zhang Y, Santini C, Sahoo SP, Berger JP, Macnaul KL, Zhou G, Agrawal A, Alvaro R, Cai TQ, Hernandez M, Wright SD, Moller DE, Heck JV, Meinke PT (2005) J Med Chem 48:5589CrossRefGoogle Scholar
  33. 33.
    Desai RC, Metzger E, Santini C, Meinke PT, Heck JV, Berger JP, Macnaul KL, Cai TQ, Wright SD, Agrawal A, Moller DE, Sahoo SP (2006) Bioorg Med Chem Lett 16:1673CrossRefGoogle Scholar
  34. 34.
    Fyffe SA, Alphey MS, Buetow L, Smith TK, Ferguson MA, Sorensen MD, Bjorkling F, Hunter WN (2006) J Mol Biol 356:1005CrossRefGoogle Scholar
  35. 35.
    Takada I, Yu RT, Xu HE, Lambert MH, Montana VG, Kliewer SA, Evans RM, Umesono K (2000) Mol Endocrinol 14:733CrossRefGoogle Scholar
  36. 36.
    Yanagisawa H, Takamura M, Yamada E, Fujita S, Fujiwara T, Yachi M, Isobe A, Hagisawa Y (2000) Bioorg Med Chem Lett 10:373CrossRefGoogle Scholar
  37. 37.
    Rybczynski PJ, Zeck RE, Dudash JJ, Combs DW, Burris TP, Yang M, Osborne MC, Chen X, Demarest KT (2004) J Med Chem 47:196CrossRefGoogle Scholar
  38. 38.
    Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM (1996) J Med Chem 39:665CrossRefGoogle Scholar
  39. 39.
    Ostberg T, Svensson S, Selen G, Uppenberg J, Thor M, Sundbom M, Sydow-Backman M, Gustavsson AL, Jendeberg L (2004) J Biol Chem 279:41124CrossRefGoogle Scholar
  40. 40.
    Arlt W, Neogi P, Gross C, Miller WL (2004) J Mol Endocrinol 32:425CrossRefGoogle Scholar
  41. 41.
    Trifilieff A, Bench A, Hanley M, Bayley D, Campbell E, Whittaker P (2003) Br J Pharmacol 139:163CrossRefGoogle Scholar
  42. 42.
    Sauerberg P, Pettersson I, Jeppesen L, Bury PS, Mogensen JP, Wassermann K, Brand CL, Sturis J, Woldike HF, Fleckner J, Andersen AS, Mortensen SB, Svensson LA, Rasmussen HB, Lehmann SV, Polivka Z, Sindelar K, Panajotova V, Ynddal L, Wulff EM (2002) J Med Chem 45:789CrossRefGoogle Scholar
  43. 43.
    Liu KG, Lambert MH, Ayscue AH, Henke BR, Leesnitzer LM, Oliver WRJ, Plunket KD, Xu HE, Sternbach DD, Willson TM (2001) Bioorg Med Chem Lett 11:3111CrossRefGoogle Scholar
  44. 44.
    Henke BR, Blanchard SG, Brackeen MF, Brown KK, Cobb JE, Collins JL, Harrington WWJ, Hashim MA, Hull-Ryde EA, Kaldor I, Kliewer SA, Lake DH, Leesnitzer LM, Lehmann JM, Lenhard JM, Orband-Miller LA, Miller JF, Mook RAJ, Noble SA, Oliver WJ, Parks DJ, Plunket KD, Szewczyk JR, Willson TM (1998) J Med Chem 41:5020CrossRefGoogle Scholar
  45. 45.
    Epple R, Azimioara M, Russo R, Bursulaya B, Tian SS, Gerken A, Iskandar M (2006) Bioorg Med Chem Lett 16:2969CrossRefGoogle Scholar
  46. 46.
    Li Z, Liao C, Ko BC, Shan S, Tong EH, Yin Z, Pan D, Wong VK, Shi L, Ning ZQ, Hu W, Zhou J, Chung SS, Lu XP (2004) Bioorg Med Chem Lett 14:3507CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Patrick Markt
    • 1
  • Daniela Schuster
    • 1
    • 2
  • Johannes Kirchmair
    • 1
    • 2
  • Christian Laggner
    • 1
  • Thierry Langer
    • 1
    • 2
  1. 1.Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI)University of InnsbruckInnsbruckAustria
  2. 2.Inte:Ligand Softwareentwicklungs- und Consulting GmbHMaria EnzersdorfAustria

Personalised recommendations